Author:
Abikhzer Gad,Levett Jeremy Y.,Sebag Igal A.,Pelletier-Galarneau Matthieu
Publisher
Springer International Publishing
Reference62 articles.
1. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73.
2. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015;132(15):1435–86.
3. Topan A, Carstina D, Slavcovici A, Rancea R, Capalneanu R, Lupse M. Assessment of the Duke criteria for the diagnosis of infective endocarditis after twenty-years. An analysis of 241 cases. Clujul Med. 2015;88(3):321–6.
4. Habib G, Derumeaux G, Avierinos JF, Casalta JP, Jamal F, Volot F, et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J Am Coll Cardiol. 1999;33(7):2023–9.
5. Abikhzer G, Martineau P, Gregoire J, Finnerty V, Harel F, Pelletier-Galarneau M. [(18)F]FDG-PET CT for the evaluation of native valve endocarditis. J Nucl Cardiol. 2020;29(1):158–65.